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Abstract  
 
Context. Whether infertile women exhibit accelerated ovarian aging and a low ovarian 
reserve is over-represented in infertility populations is unknown.  
Objective. To compare the age-related decline in antral follicle count (AFC), a 
biomarker of the ovarian reserve, in fertile and infertile women.  
Design. Cross-sectional data from a large prospective cohort study conducted from 
January 2013 to December 2014. 
Setting. 13 fertility centers across Spain. 
Patients or Other Participants. Consecutive women aged 18 to 45 years of age 
attending the fertility centers either seeking fertility treatment or as fertile women 
wishing to act as potential oocyte donors.  
Intervention(s). Standardized AFC assessment on day 2 to 4 of the cycle.  
Main Outcome Measure(s). Age-related decline of AFC for both fertile and infertile 
women.  
Results. 15,500 women of whom 5,722 were potential donors and 9,778 were patients 
seeking fertility treatment. Average AFC was greater in potential oocyte donors than 
in infertile women (20 (interquartile range (IQR) 16, 24) vs 10 (IQR 6, 15), p<0.001, 
a difference which was maintained after adjustment for age (p<0.001 in model 
predicting log(AFC) from donor vs. infertility, adjusting for two-year age bands). The 
age-related decline in AFC was much steeper in infertile women compared with that 
of potential oocyte donors, with an increased prevalence of a low ovarian reserve 
(AFC<5) at all ages in infertile women.  
Conclusions. The age-related decline in AFC was substantially greater in infertility 
patients than potential oocyte donors. Over-representation in infertility populations of 
women with low ovarian reserve may be an additional functional cause of infertility.  
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Introduction 
Reproductive ageing is underpinned by concurrent depletion of the follicular pool and 
a decline in oocyte quality (1). Composite models of the number of non-growing 
follicles (NGF) that constitute the ovarian reserve from birth to menopause expose 
substantial variation between individuals (2,3). Whether with the postponement of 
parenthood and increased maternal age, biological variation in the ovarian reserve 
may also contribute to the increased prevalence of infertility is unknown.  
 
Despite the ovarian reserve being a critical determinant of reproductive milestones 
such as the age of optimal fertility, sterility, and menopause (4-8), it cannot be readily 
assessed. Several biomarkers that correlate numerically or physiologically with NGF 
have been proposed as surrogates (3,9-11). Only antral follicle count (AFC) and anti-
müllerian hormone (AMH) exhibit strong associations with histologically determined 
NGF number and functional measures of the ovarian reserve such as ovarian response 
to stimulation (12). The age-related decline in AMH has been well established (13-
15), however, comparison of ovarian aging between fertile and non-fertile populations 
has been constrained due to ongoing assay development and lack of standardization 
(12).  
 
For AFC, development of age-specific population reference ranges has been limited 
primarily due to the invasive nature of transvaginal ultrasound for known fertile 
healthy populations and secondly inconsistencies in the technical aspects of AFC 
measurement (12). The latter has recently been resolved with the publication of a 
consensus statement setting the technical standards of AFC measurement (16), 
whereas the former limitation has yet to be tackled. Small single-center studies 
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(N=362 - 1,866) have reported a negative association between age and AFC (17-19). 
However, these models were developed from small single site studies of fertile 
women (n=362 (17), n=366 (19), n=(771)) (20), or aggregated data sets from 
infertility patients (n=1,866) (21) across multiple clinical settings and countries using 
non-standardized ultrasound methodology, and none were validated, rendering their 
extrapolation to normal reproductive ageing limited. 
 
To examine whether reproductive aging is similar between fertile and non-fertile 
women we sought to develop, compare and validate population models describing the 
age-related decline in AFC in women without a history of infertility (potential oocyte 
donors) as compared to women seeking fertility treatment.  
 
Materials and Methods 
Study design and participants 
A prospective cross-sectional study conducted in 13 IVI infertility centers across 
Spain from January 2013 to December 2014. Consecutive women attending the 
clinics either for fertility treatment or as potential oocyte donors were included in the 
study. In Spain, ovum donation is anonymous. Donors must be between 18 and 35 
years old, be healthy without a family history of inherited or chromosomal conditions, 
and have normal gynecologic examination results and a negative screening for 
infectious diseases. The overall analysis was restricted to women aged 18 to 45 years 
without missing AFC data as reproductive indicators vary substantially at the 
extremes of reproductive age. Data were collected anonymized and each patient was 
allocated a unique identifier number. Demographic and lifestyle information were 
self-reported. The vast majority of the women were of white European decent.  
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AFC measurement  
All patients underwent standardized AFC assessment at day 2 to 4 of their cycle in 
accordance with recent consensus statements (16). All ultrasound scans were 
performed by medical personnel appropriately trained in transvaginal sonography 
with the use of identical equipment on all sites incorporating a 7-10 MHz probe 
(Voluson 730 Expert, GE Healthcare, Milwaukee, WI, USA). Only follicles 
measuring 2-10 mm in diameter were included in the AFC. AFC measurements were 
subject to routine quality control measurements. 
 
Statistical analysis 
The datasets from the different centers were merged and cases with missing age or 
AFC information excluded. AFC was compared between oocyte donors and infertile 
women for different age bands. The relation of AFC to age was modeled separately 
for donors and infertility patients by predicting the log-transformed AFC values from 
a penalized thin-plate regression spline of age (22). The smoothing parameter was 
estimated using generalized cross-validation. 
 
Model fit was assessed and validated through a 5-fold cross validation. The root mean 
square error (RMSE) was calculated to summarize the model fit. The RMSE is the 
sample standard deviation of the difference between the observed values and the 
values predicted by the model. It is a measure of accuracy where 0 would be perfect 
accuracy of the prediction. Reference plots for donors and infertility patients were 
generated showing predicted percentiles for AFC by age. Prediction intervals were 
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calculated assuming a normal distribution of the residuals for log AFC and then 
transformed back on the original scale. 
 
Sensitivity analysis was performed to assess whether cycle irregularity (women were 
stratified to those with regular cycles between 25 to 35 days, shorter cycles < 25 days 
and longer cycles > 35 days) or different percentiles of AFC modifies the decline of 
AFC with advancing age.  We also checked whether different operators modify the 
association between AFC and age by assessing the significance of the interaction term 
including the operator variable in the model at the conventional level of p<0.05. 
 
All analyses were performed using R version 3.0.1 (23). 
 
Results 
Population 
15,500 women aged between 18 to 45 years with a valid AFC measurement were 
included in the analyses, of whom 5,722 were potential oocyte donors and the 
remaining 9,778 were patients seeking fertility treatment. Table 1 shows the 
demographic characteristics of the cohort stratified to potential oocyte donors and 
infertility patients. Potential Oocyte donors were younger than infertile women (25.2 
(standard deviation (SD): 4.3) vs 36.7 (SD: 3.9) years, p<0.001). The difference in 
BMI was statistically significant, but not clinically relevant among the groups (22.3 
(SD: 2.8) for potential oocyte donors vs 23.0 (SD: 3.6) kg.m-2 for infertile women, 
p<0.001). Average AFC was greater in potential oocyte donors than in infertile 
women (20 (interquartile range (IQR) 16, 24) vs 10 (IQR 6, 15), p<0.001, a difference 
which was maintained after adjustment for age (p<0.001 in model predicting log 
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(AFC) from donor vs. infertility, adjusting for two-year age bands). Table 2 shows the 
AFC in potential oocyte donors and infertility patients stratified by age; the potential 
oocyte donors have substantially greater AFC for any given age over 25 years 
compared with the infertility patients of similar age. Hence, the discrepancy in the 
average AFC between potential oocyte donors and infertility patients is not driven by 
the age difference between the two groups. 
 
Age-related decline in AFC 
Figure 1 shows the average decline in AFC across all ages for potential oocyte donors 
and infertility patients. The decline of AFC with age was substantially steeper in 
women with a history of infertility than in potential oocyte donors for the comparable 
age range up to 35 years. Supplemental Figure 1 shows the decline in AFC in 
potential oocyte donors and infertility patients for different percentiles of AFC 
demonstrating that for AFC ≥ 25th percentile for each group the rate of decline of 
AFC becomes steeper with advancing age in the infertility patients compared with the 
oocyte donors. The dashed continuation of the line for potential oocyte donors for 
ages over 35 years was based on model extrapolation. The RMSE for potential oocyte 
donors and infertility patients was 0.32 and 0.62 respectively. In the analysis 
comparing AFC in donors with infertile women, the interaction term including the 
operator variable was not significant to the conventional level of p<0.05 (p= 0.31), 
which means that operator dependent variation in AFC did not modify substantially 
the associations between AFC and study groups, hence stratification of the analysis 
per operator was not warranted 
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Figures 2.1 and 2.2 demonstrate the reference plots of AFC relative to age for 
potential oocyte donors and infertility patients respectively. The wide solid line shows 
the predicted median AFC value along with aging, whereas the thin solid lines show 
different prediction percentiles as labeled. Grey shading and dashed lines in the 
reference plot for donors indicate extrapolated results beyond the maximum age of 35 
years in our dataset. Supplemental Figure 2 shows that the rate of decline of AFC 
with age in women with regular, short or long cycles does not differ substantially in 
either potential oocyte donors or infertility patients. 
 
Prevalence of low AFC within infertile women and women without a history of 
infertility 
International consensus has defined a low ovarian reserve as an AFC <5 (24). Figure 
2 demonstrates that, among infertile women, 1%, 5% and 10% of the population at the 
age of 20, 30 and 35 years respectively had low AFC. Whereas, among potential 
oocyte donors, <1% of the women had low AFC at the age of 20, 30 or 35 years. 
Hence, low ovarian reserve assessed with AFC is more prevalent among infertile 
women from almost the age of 20 to at least the age of 35 years.  
 
Discussion 
To our knowledge, this is the largest study (n=15,500) to evaluate the age-related 
decline in ovarian reserve assessed by AFC in both potential oocyte donors and 
infertility patients and generate age-related reference ranges of AFC that will be 
valuable in clinical practice. Furthermore, we confirmed the prevailing assumption 
that women with low ovarian reserve are overrepresented within infertile populations, 
who exhibit a greater decline in AFC with aging compared with women without a 
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history of infertility. In addition, subgroup analysis demonstrated that decline in AFC 
in the infertility group was steeper almost universally irrespective of the percentile 
AFC or cycle length. 
 
The age-related decline in AFC has been modeled before in smaller samples of 
infertile (n=1,866) (21) or fertile women (n=362 (17) or n=366 (19)) suggesting a 
biphasic or linear decline in AFC with aging respectively. Our study in substantially 
larger populations and by using refined statistical methodology disembarks from the 
concept of the exponential decline model and suggests a smoother decline in AFC in, 
at least, infertile patients that mirrors the decline in NGF recruitment, the process that 
feeds AFC (2). This supports further the physiological connection between AFC, 
NGF and ovarian reserve and grants biological plausibility to our model. The spline 
modeled decline in AFC in the population of potential oocyte donors, who represent 
women of normal fertility potential (n=5,722), was closer to the linear model in line 
with the smaller studies in non-infertile women (17,19). However, we acknowledge 
that the model may have deviated from linearity if women over the age of 35 years, 
almost at the age when NGF recruitment slows down and plateaus (2), were 
represented in this group.  
 
In comparison with the previously published normograms (17,18), our average 
predicted AFC for any given age was higher for both fertile and infertile women. This 
numerical discrepancy may be mainly attributed to the contemporary nature of our 
study and the associated technical advancement in transvaginal sonography enabling 
practitioners to visualize and thereby quantify a larger number of follicles (25). 
Similarly, the reference ranges of AFC for oocyte donors suggest that up to the age of 
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35 years at least 25% of the women would have polycystic ovary (PCO) morphology 
based on the 2003 Rotterdam criteria (26), whereas with the recommendations of 
most recent studies suggesting that PCO morphology should be defined of at least 25 
follicles per ovary (hence AFC of at least 50) (25,27) a small proportion of them 
would be classified as having PCO appearance. Our data would suggest that an 
upwards shift of the normal AFC range is required possibly due to technical 
advancements in sonography and provide further support for the need to redefine 
PCO morphology (27). However, we cannot exclude that the small proportion of 
women with PCO appearance in the oocyte donor group may imply a unique self-
selected group which is not entirely representative of the general population.  
 
Women with infertility demonstrated a steeper age-related decline in their AFC 
compared with potential oocyte donors, despite both groups having an almost 
identical starting point in their ovarian reserve at the age of 18 years. Whether this is 
mainly a result of overrepresentation of women with low ovarian reserve among 
infertile patients especially in the second half of reproductive lifespan or indicates an 
additional accelerated ovarian aging, and thereby earlier menopause (6), in women 
with infertility is unclear. Our findings are in keeping a previous smaller study (n=881 
infertile women, n=771 controls) indicating a substantial discrepancy in ovarian 
reserve between infertile women and women without a history of infertility and 
provides further evidence to the dominant theory that follicular pool depletion 
contributes to female infertility (20). Prospective longitudinal data are warranted to 
clarify the source of discrepancy in AFC decline between the two populations. 
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Our age-specific normograms resulted from robust modeling and cross-validation 
methodology and generated age reference ranges of AFC for both infertile and fertile 
populations of white descent. Normograms have great clinical value and can be used 
by clinicians for a pictorial representation of AFC range when consulting patients. 
This would enable patients to comprehend where their ovarian reserve stands within 
the normal range for their age and grasp the concept of percentile curves. Given that 
AFC has been suggested as a potential predictor of the age of menopause (28) or loss 
of fertility (6), age-related normograms can demonstrate clearer to lay people why a 
woman in the lowest percentiles curves of AFC is more likely to have a depleted 
ovarian reserve pool and, thereby, reach her natural sterility or menopause at a 
younger age compared with the average background population. 
 
The major strengths of our study are a large number of prospective oocyte donors and 
infertility patients, standardized ultrasound methodology, and sophisticated statistical 
analyses. The large sample size in each arm enables an accurate representation of the 
distribution of AFC for any given age along the reproductive lifespan by eliminating 
the risk of incorrect model fitting due to inadequate datapoints. Spline modeling 
allows flexibility and avoids overfitting of a model, hence, it approximates the actual 
relationship between two variables more accurately compared with simple or 
polynomial regression (29). In addition, cross-validation limits the problem of data 
overfitting and provides additional reassurance that the fitted models will perform 
well in independent datasets (29). Both groups, infertile women, and oocyte donors 
attended the clinics contemporarily and similar sonographic methodology was used 
enabling direct comparison of AFC between the two groups and minimizing the 
possibility of measurement bias. In addition, similar protocols in data collection and 
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AFC assessment were applied across all the participating reproductive centers 
eliminating inter-center variation. We acknowledge that AFC measurement is subject 
to intra- and inter-observer variation which may have an impact on assessing ovarian 
reserve at an individual level (30). However, at a population level, operator dependent 
variation is less of an issue because the age-related normogram of AFC captures the 
AFC variation for any given age, which can also be subject to different factors. In 
addition, we showed that operator variation did not modify the associations between 
AFC and age, hence, stratification of the analysis per operator was not warranted.  We 
acknowledge that the cross-sectional nature of our AFC data limits the potential for 
longitudinal extrapolation of the normograms, however, the large sample size 
compensates partially for this. Undoubtedly, longitudinal data and fitting of our 
models to external populations would provide additional validity to our findings. We 
cannot exclude that some of the oocyte donors may have been on the contraceptive 
pill during their AFC assessment. However, as long-term use of the contraceptive pill 
decreases AFC (31,32), this would only attenuate any observed differences between 
oocyte donors and infertile women. Similarly, the observed greater prevalence of 
smoking among the oocyte donors compared to the infertility patients would have 
attenuated, rather than explaining the discrepancy in AFC among the two populations. 
Lastly, the AFC for the oocyte donors was determined prior to acceptance to the 
donation program, rendering the generalizability of the data to normal healthy 
populations acceptable. However, we acknowledge that oocyte donors may represent 
a self-selected group which is not entirely representative of the general population. In 
particular their observed low rate of age-related decline in AFC may have 
exaggerated the discordance between them and the infertile women. Hence, validation 
of the normogram in the general population is warranted. 
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We conclude that AFC declines with advancing age in both potential oocyte donors 
and infertile women. The extent of the decline is substantially larger in infertile 
women, potentially reflecting that women with low ovarian reserve are 
overrepresented within the infertile population. We have generated age-related 
reference ranges of AFC for both populations that can be valuable tools in clinical 
settings and facilitate patient consultation. Longitudinal data and external validation 
would add extra weight to our results. 
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Table 1: Demographic characteristics of potential oocyte donors and infertility patients. Data are presented as mean (standard deviation (SD) or 
median (Interquartile Range (IQR), unless stated otherwise. 
Characteristics Oocyte Donors Infertility Patients P-value 
N 5,722 9,778  
Age (years) 25.2 (4.3) 36.7 (3.9) < 0.001 
BMI (kg.m-2) 22.3 (2.8) 23.0 (3.6) < 0.001 
Antral Follicle Count (n) 20.0 (16.0, 24.0) 10.0 (6.0, 15.0) < 0.001 
Current Smokers (n, %) 2,853 (49.9%) 1,646 (16.8%) < 0.001 
Menstrual cycle (days) 28.4 (3.6) 28.6 (6.3) < 0.001 
Menstrual cycle <25 days (n, %) 115 (2.0%) 491 (5.0%) < 0.001 
Menstrual cycle >35 days (n, %) 107 (1.9%) 299 (3.1%) <0.001 
Causes of Infertility (N, %) 
Ovulatory factor 
PCOS 
Tubal factor 
NA  
1,767 (18.1%) 
759 (7.8%) 
413 (4.2%) 
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Advanced Age 
Idiopathic 
Endometriosis 
Recurrent miscarriages 
Genetic factors 
Other 
2,584 (26.4%) 
3,153 (32.2%) 
606 (6.2%) 
237 (2.4%) 
163 (1.7%) 
96 (1.0%) 
Previous term pregnancy (N, %) 
Missing (N, %) 
1,988 (35.6) 
136 (2.4) 
776 (10.5) 
2,392 (24.5) 
< 0.001 
Previous miscarriage (N, %) 
Missing (N, %) 
349 (6.6) 
443 (7.7) 
1,744 (22.6) 
2,069 (21.2) 
< 0.001 
Previous termination of pregnancy (N, %) 
Missing (N, %) 
1,440 (26.3) 
245 (4.3) 
559 (8.7) 
3326 (34.0) 
< 0.001 
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Table 2: Antral Follicle Count (AFC) stratified by age in potential oocyte donors and infertility patients.  
Interquartile range (IQR) 
 
 
Age bands 
(years) 
Number of 
donors  
AFC oocyte donors  
Median (IQR) 
Number of 
infertility 
patients 
AFC infertility patients 
Median (IQR) 
p-value 
≤ 25 3,100 21.0 (17.0, 25.0) 61 20.0 (12.0, 27.0) 0.338 
26-27 779 20.0 (16.0, 24.0) 113 17.0 (12.0, 22.0) < 0.001 
28-29 749 19.0 (15.0, 23.0) 252 16.0 (11.0, 21.2) < 0.001 
30-31 610 18.0 (15.0, 22.0) 524 16.0 (11.0, 21.2) < 0.001 
32-33 389 18.0 (14.0, 22.0) 1,023 13.0 (9.0, 19.0) < 0.001 
34-35 95 18.0 (14.0, 22.0) 1,452 11.0 (8.0, 16.0) < 0.001 
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Figures and Legends 
 
Figure 1: Spline prediction decline of Antral Follicle Count (AFC) with aging in 
potential donors (blue line) and infertility patients (red line).  
 23 
Figure 2: Age specific ranges of AFC in potential oocyte donors (A) and women 
seeking fertility treatment (B). Black lines represent percentiles as labeled. The grey 
shaded area in A for donors over the age of 35 years have resulted from extrapolation 
of the spline prediction model. 
 24 
Supplemental Figure 1: Spline prediction decline of Antral Follicle Count (AFC) 
with aging in potential donors (blue line) and infertility patients (red line) for different 
percentile categories of AFC.   
 25 
Supplemental Figure 2: Average age-related decline (with 95% confidence 
intervals) of Antral Follicle Count (AFC) stratified by cycle length in potential oocyte 
donors and infertility patients.  
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